Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2008
11/27/2008WO2007143468A3 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
11/27/2008WO2007106852A3 Substituted fused[1,2]imidazo[4,5-c] ring compounds and methods
11/27/2008WO2005025498A3 Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation
11/27/2008US20080293947 Method of Preparation for Imidazolepyridines
11/27/2008US20080293946 Process for Preparing Zolpidem Hemitartrate and Tartrate Polymorphs
11/27/2008US20080293761 Pyrrolopyridine-2-Carboxylic Acid Amide Derivative Useful as Inhibitor of Glycogen Phosphorylase
11/27/2008US20080293760 Gemifloxacin Process and Polymorphs
11/27/2008US20080293757 Abca1 elevating compounds
11/27/2008US20080293756 4,4-disubstituted piperidine derivatives
11/27/2008US20080293745 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/27/2008US20080293743 (5S)-5-({[6-(2-cyclopropylpyrimidin-5-yl)-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)-5-methylimidazolidine-2,4-dione; asthma, chronic obstructive pulmonary disease
11/27/2008US20080293732 Substituted pyrazoles
11/27/2008US20080293716 Benzamide rho-kinase (ROCK-1) inhibitors; N-(2-phenylethyl)-5-(4-pyridinyl)-2-thiophenecarboxamide
11/27/2008US20080293712 Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof
11/27/2008US20080293694 New compounds
11/27/2008US20080293684 Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors
11/27/2008US20080293674 Azinyl Imidazoazine and Azinyl Carboxamide
11/27/2008US20080293664 Non-nucleoside reverse transcriptase inhibitors
11/27/2008US20080293650 Fused Heterocyclic Compounds and Use Thereof
11/27/2008US20080293646 Macrolides
11/27/2008US20080293573 Use as pesticide, microbiocide, or herbicide
11/27/2008DE102007023747A1 Organisches elektrochromes Bauelement für Daueranzeigen Organic electrochromic device for continuous displays
11/27/2008CA2688008A1 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
11/27/2008CA2686485A1 Purinones and 1h-imidazopyridinones as pkc-theta inhibitors
11/27/2008CA2686016A1 Quinoline derivatives as pi3 kinase inhibitors
11/27/2008CA2685942A1 Spiroindalones
11/27/2008CA2684764A1 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
11/27/2008CA2684147A1 Urotensin ii receptor antagonists
11/27/2008CA2683350A1 Nitrogenous heterocyclic compounds, preparation thereof and use thereof a antibacterial medicaments
11/26/2008EP1995240A1 Quinolone derivative or pharmaceutically acceptable salt thereof
11/26/2008EP1994033A1 Indolopyridines as eg5 kinesin modulators
11/26/2008EP1994032A1 Pyrazole derivatives as sigma receptor inhibitors
11/26/2008EP1994022A2 N-substituted-azacyclylamines as histamine-3 antagonists
11/26/2008EP1994020A2 Substituted quinolones iii
11/26/2008EP1994015A1 Dibenzyl amine derivatives as cetp inhibitors
11/26/2008EP1994011A1 Sulfonyl benzimidazole derivatives
11/26/2008EP1768980B1 Improved process for the manufacture of mirtazapine
11/26/2008EP1763528B1 Pyrazolopyridine derivatives
11/26/2008EP1756084B1 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
11/26/2008EP1603913B1 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives
11/26/2008EP1546149B1 Modified pictet-spengler reaction and products prepared therefrom
11/26/2008EP1534707B9 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/26/2008EP1337517B1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
11/26/2008EP1311487B1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
11/26/2008CN101312976A Spirocyclic compounds as hdac inhibitors
11/26/2008CN101312975A Method for 1h-imidazo[4,5-c]pyridines and analogs thereof
11/26/2008CN101312974A Pyrazoloisoquinoline derivatives
11/26/2008CN101312973A Novel indolizine derivatives, method for preparing same and therapeutic compositions comprising same
11/26/2008CN101312972A Bicyclic cinnamide compound
11/26/2008CN101312971A Substituted bicyclic pyrimidone derivatives
11/26/2008CN101312970A 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
11/26/2008CN101312969A Azaindole-2-carboxamide derivatives
11/26/2008CN101312955A Process for producing optically active piperazine compound
11/26/2008CN101311176A Isoquinoline compounds, preparation method and use thereof
11/26/2008CN101310771A Visual function disorder improving agents
11/26/2008CN100436456C Imidazo [4,5-b] pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum
11/26/2008CN100436453C Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436425C Fused imidazolium derivatives
11/25/2008US7456286 Bicyclic heteroaromatic compounds as kinase inhibitors
11/25/2008US7456196 Alzheimer's disease; antihistamine; attention deficit disorder; hyperactivity; bipolar disorder; cognition activators; psychological disorder; anticancer agent; antidepressants; antiepileptic agents; gastrointestinal disorder; analgesics; 6-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-2-(3-pyridinyl)quinoline
11/25/2008US7456194 Imidazo-fused oxazolo [4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
11/25/2008US7456193 Disorders of GABAergic transmission associated with GABAA receptor subtypes, such as anxiety, sleep disorders, epilepsy; 1,6-dimethyl-3-(pyridin-4-yl)-1,9-dihydro-2H-pyrido[2,3-b]indol-2-one
11/25/2008US7456192 3β-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereof
11/25/2008US7456177 Heteroaryl fused azapolycyclic compounds which bind to neuronal nicotinic acetylcholine specific receptor sites, and which are useful in modulating cholinergic function, for for reducing nicotine addiction or aiding in the cessation or lessening of tobacco use in a mammal, therapy
11/25/2008US7456168 2-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-ones
11/25/2008US7455917 Organic compound and organic light emitting device using the same
11/25/2008CA2318579C Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
11/25/2008CA2271136C Novel pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient
11/20/2008WO2008141249A1 Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors
11/20/2008WO2008141239A1 Imidazol [1,2-a] pyridines and related compounds with activity at cannabinoid cb2 receptors
11/20/2008WO2008140646A2 Process for the synthesis of cmhtp and intermediates thereof
11/20/2008WO2008140641A2 Pure paliperidone and processes for preparing thereof
11/20/2008WO2008140239A1 Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same
11/20/2008WO2008140198A1 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
11/20/2008WO2008139452A2 Selective bromination of perylene diimides and derivatives thereof under mild conditions
11/20/2008WO2008139288A2 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
11/20/2008WO2008138920A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
11/20/2008WO2008138878A2 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/20/2008WO2008138759A1 Process for the preparation of moxifloxacin hydrochloride
11/20/2008WO2008138232A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof
11/20/2008WO2008121687A3 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
11/20/2008WO2008117225A3 New imidazolo-heteroaryl derivatives with antibacterial properties
11/20/2008WO2008113559A3 Indolizines and aza-analog derivatives thereof as cns active compounds
11/20/2008WO2008111077A3 Self-assembled polyhedral multimeric chemical structures
11/20/2008WO2008030412A3 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
11/20/2008WO2008027812A3 Imidazopyridine and imidazopyrimidine derivatives
11/20/2008WO2007138041A8 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use
11/20/2008WO2007138040A8 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use
11/20/2008US20080287678 Multiple Chromophores Based on Rylene
11/20/2008US20080287504 Such as N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; Cannabinoid-1 (CB1) receptor; dietetics
11/20/2008US20080287485 Novel indolizine derivatives, method for preparing same, and therapeutic compositions comprising same
11/20/2008US20080287484 Neurotrophin antagonist compositions
11/20/2008US20080287478 Nociceptin Analogues and Uses Thereof
11/20/2008US20080287472 Fungicides
11/20/2008US20080287468 Purine and imidazopyridine derivatives for immunosuppression
11/20/2008US20080287462 New compounds 834
11/20/2008US20080287458 Dihydroquinone and dihydronaphthridine inhibitors of JNK
11/20/2008US20080287454 Cxcr4 antagonists
11/20/2008US20080287449 Aza-tripeptide hepatitis c serine protease inhibitors